ResMed Inc. (ASX:RMD) and this ASX healthcare shares have been given buy ratings. Here’s why they could be shares to own…
The post 2 buy-rated ASX healthcare shares appeared first on The Motley Fool Australia. –
The healthcare sector has been a great place to invest over the last few years. Thanks to increasing demand due to a number of industry tailwinds, this side of the market has flourished.
The good news is that demand continues to increase and looks unlikely to stop doing so for some time to come. This could make the sector a great place to invest with a long term view.
But which ASX healthcare shares should you buy? Two to consider are listed below:
Ramsay Health Care Limited (ASX: RHC)
Few companies will benefit from increasing demand for healthcare services more than Ramsay Health Care. It is a leading private healthcare company with operations across the world.
While the pandemic led to a significant drop in elective surgeries, trading conditions have been improving greatly. As a result, Ramsay looks well-placed to benefit from a backlog in surgeries in the near term and increased demand for healthcare services over the long term.
In addition to this, the company has a long history of accelerating its growth through acquisitions. And given its strong balance sheet, it wouldn’t be overly surprising to see the company make another purchase in the near term.
One broker that is a fan of Ramsay is Macquarie. Its analysts have an outperform rating and $75.00 price target on its shares.
Another quality healthcare share to look at is ResMed. It is one of the world’s leading sleep treatment-focused medical device companies.
Thanks to its industry-leading products, growing software business, the increasing awareness of sleep disorders, and its investment in R&D, ResMed has been growing at a consistently strong rate for a number of years.
Positively, the company still has a long runway for growth. This is thanks to its huge addressable market and the shift to home healthcare. The latter is being supported by its comprehensive out-of-hospital software platforms.
Morgans is bullish on ResMed. It currently has an add rating and $30.09 price target on its shares.
Where to invest $1,000 right now
When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*
Scott just revealed what he believes are the five best ASX stocks for investors to buy right now. These stocks are trading at dirt-cheap prices and Scott thinks they are great buys right now.
*Returns as of February 15th 2021
- 2 brilliant blue chip ASX 200 shares brokers love
- The latest 3 ASX shares leading brokers are urging you to buy now
- 3 fantastic ASX shares to buy this month
- 3 of the best ASX shares to buy this month
- 2 quality ASX shares to buy and hold for a very long time
Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia has recommended Ramsay Health Care Limited and ResMed Inc. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.